Back
Daiichi Sankyo Vs. Nxera Pharma Industry Stock Comparison
Buy
63
DSNKY
Daiichi Sankyo
Last Price:
33.37
Seasonality Move:
4.17%
Sell
15
SOLTF
Nxera Pharma
Last Price:
9.30
Seasonality Move:
15.46%
Buy
63
Daiichi Sankyo (DSNKY)
is a Buy
Is Daiichi Sankyo a Buy, Sell or Hold?
- The current Daiichi Sankyo [DSNKY] share price is $33.37. The Score for DSNKY is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- DSNKY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
15
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $9.30. The Score for SOLTF is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
DSNKY Stock Price Chart
What is Daiichi Sankyo's stock price today?
-
The Daiichi Sankyo share price today is $33.37
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSNKY is experiencing selling pressure, which indicates risk of future bearish movement.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $9.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing slight buying pressure.
DSNKY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 68.69 | Buy |
| Chaikin Money Flow: | -383455 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.64 - 31.94) | Buy |
| Bollinger Bands (100): | (28.52 - 32.5) | Buy |
SOLTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 30.53 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.6 - 10.52) | Sell |
| Bollinger Bands (100): | (9.26 - 10.8) | Sell |
DSNKY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.28 | Buy |
| 20-day SMA: | 30.58 | Buy |
| 50-day SMA: | 31.8 | Buy |
| 200-day SMA: | 29.23 | Buy |
| 8-day EMA: | 31.64 | Buy |
| 20-day EMA: | 31.1 | Buy |
| 50-day EMA: | 31.1 | Buy |
| 200-day EMA: | 30.24 | Buy |
SOLTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.56 | Sell |
| 20-day SMA: | 9.91 | Sell |
| 50-day SMA: | 10.08 | Sell |
| 200-day SMA: | 10.3 | Sell |
| 8-day EMA: | 9.54 | Sell |
| 20-day EMA: | 9.84 | Sell |
| 50-day EMA: | 10.02 | Sell |
| 200-day EMA: | 10.92 | Sell |
Daiichi Sankyo Earnings Growth & DSNKY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Daiichi Sankyo Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nxera Pharma Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||